Artículos recomendados

nature-reviews

Nature Reviews / NEUROSCIENCE

Volumen 9, Número 10, Páginas 768-778; Octubre, 2008

Thirty years of Alzheimer’s disease genetics: the implications of systematic meta-analyses.

Lars Bertram and Rudolph E. Tanzi

Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Diseases (MIND), Department of Neurology, Massachusetts General Hospital, 114 16th Street, Charlestown, Massachusetts 02129, USA.

neurology

Neurobiology of Aging

Volume 28, Issue 10, Pages 1465-1636; October, 2007

Is aging part of Alzheimer’s disease, or is Alzheimer’s disease part of aging?

Russell H. Swerdlow

Department of Neurology, University of Virginia Health System, McKim Hall, 1 Hospital Drive, P.O. Box 800394, Charlottesville, VA 22908, United States.

trends

TRENDS in Molecular Medicine

Volumen 11, Número 4, Páginas 145-197; Abril, 2005

Tau phosphorylation in Alzheimer’s disease: pathogen or protector?

Hyoung-gon Lee (1), George Perry (1), Paula I. Moreira (1), (2), Matthew R. Garrett (1), Quan Liu (1), Xiongwei Zhu (1), Atsushi Takeda (3), Akihiko Nunomura (4) and Mark A. Smith (1)

1. Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106 USA. 2. Center for Neuroscience and Cell Biology of Coimbra, University of Coimbra, 3004-517 Coimbra, Portugal. 3. Department of Neurology, Tohoku University School of Medicine, Sendai, Miyagi 980-8574, Japan. 4. Department of Psychiatry and Neurology, Asahikawa Medical College, Asahikawa 078-8510, Japan.

cover1

Physiological Reviews

Volume 84, Issue 2, Pages 361-384; April, 2004

Role of Tau Protein in Both Physiological and Pathological Conditions

Jesús Avila, José J. Lucas, Mar Pérez, and Félix Hernández.

Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM), Facultad de Ciencias, Campus de Cantoblanco, Madrid, Spain

neurology

Neurobiology of Aging

Volumen 25, Número 3, Páginas 273-416; Marzo, 2004

Neurochemical diagnosis of Alzheimer’s dementia by CSF A42, A42/A40 ratio and total tau

Piotr Lewczuk a, Hermann Esselmann b , Markus Otto b , Juan Manuel Maler a , Andreas Wolfram Henkel a , Maria Kerstin Henkel a , Oliver Eikenberg c , Christof Antz c , Wolf-Rainer Krause d , Udo Reulbach e , Johannes Kornhuber, Jens Wiltfang a.

a Molecular Neurobiology Lab, Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg, Schwabachanlage 6, 91054 Erlangen, Germany. b Department of Psychiatry, University of Goettingen, von-Siebold-Str. 5, 37075 Goettingen, Germany. c ABETA GmbH, Im Neuenheimer Feld 584, 69120 Heidelberg, Germany. d Department of Psychiatry and Psychotherapy, Thiestr. 7-10, 38889 Blankenburg, Germany. e Department of Medical Informatics,…

pharmacology

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY

Volumen 43, Páginas 545-584; Abril, 2003

ALZHEIMER’S DISEASE: Molecular Understanding Predicts Amyloid-Based Therapeutics

Dennis J. Selkoe¹ and Dale Schenk²

¹Harvard Medical School and Brigham and Women’s Hospital, Boston, Massachusetts 02115 ²Elan Pharmaceuticals, South San Francisco, California 94080

sarasadoc2

La Enfermedad de Alzheimer

Manuel Sarasa

Director Científico de Araclon Biotech, Zaragoza, España.

Descargar PDF

PHYSIOLOGICAL

PHYSIOLOGICAL REVIEWS

Volumen 81, Número 2, Páginas 741-766; Abril, 2001

Alzheimer’s Disease: Genes, Proteins, and Therapy

Dennis J. Selkoe

Department of Neurology and Program in Neuroscience, Harvard Medical School, and Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, Massachusetts.

Descargar PDF